跳转至内容
Merck

Piroxicam induced pulmonary infiltrates and eosinophilia.

The Journal of rheumatology (1994-08-01)
P Pfitzenmeyer, M Meier, P Zuck, G Peiffer, P Masson, A Turcu, F Piard, P Camus
摘要

We describe 2 patients who developed pulmonary infiltrates while being treated with piroxicam. There was no satisfactory explanation other than drug induced lung disease for their illness. They had no exposure to pneumotoxic drugs or aerocontaminants. Microorganisms were not cultured in sputum or bronchoaveolar lavage. There was no underlying illness with possible lung involvement. Pulmonary infiltrates developed during piroxicam therapy, disappeared after drug withdrawal and recurred following rechallenge.

材料
货号
品牌
产品描述

Sigma-Aldrich
吡罗昔康, ≥98% (TLC)
USP
吡罗昔康, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
吡罗昔康, meets USP testing specifications
吡罗昔康, European Pharmacopoeia (EP) Reference Standard
吡罗昔康, European Pharmacopoeia (EP) Reference Standard